Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
51.94 USD | -3.61% |
|
+17.62% | +13.55% |
08/07 | Rhythm Pharmaceuticals Appoints Alastair Garfield as Chief Scientific Officer | MT |
08/07 | Rhythm Pharmaceuticals, Inc. Announces Appointment of Alastair Garfield, as Chief Scientific Officer | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.55% | 328.58Cr | |
+18.41% | 13TCr | |
+23.18% | 12TCr | |
+23.52% | 2.79TCr | |
-18.11% | 2.1TCr | |
-15.13% | 1.69TCr | |
-14.68% | 1.62TCr | |
+9.20% | 1.48TCr | |
-46.10% | 1.48TCr | |
+52.54% | 1.41TCr |
- Stock Market
- Equities
- RYTM Stock
- News Rhythm Pharmaceuticals, Inc.
- Rhythm Pharmaceuticals, Inc. announced a financing transaction